Daily Aspirin blocks bowel cancer

A daily dose of aspirin should be given to people at high risk of bowel cancer, say scientists.

Two pills a day for two years reduced the incidence of bowel cancer by 63% in a group of 861 at-risk patients, a study reported in The Lancet said.

Newcastle University’s Prof Sir John Burn, who led the study, said the evidence “seems overwhelmingly strong”.

Other experts said the findings added to a growing body of proof that aspirin could be used in the fight on cancer.

The study was conducted on 861 patients with Lynch syndrome, which affects one in every 1,000 people.

For full story, click here.

 

Raw vegetables and fruits counteract heart risk genes

People who are genetically susceptible to heart disease can lower their risk by eating plenty of fruit and raw vegetables, a study suggests.

It says five or more daily portions should be enough to counteract culprit versions of a gene on chromosome 9, thought to be possessed by a fifth of people of European ancestry.

Healthy diets appeared to weaken its effect.

The US researchers investigated more than 27,000 people for their work.

The findings were published in Plos Medicine journal.

These participants came from from around the globe, including Europe, China and Latin America.

The results suggest that individuals with high risk 9p21 gene versions who consumed a diet packed with raw vegetables, fruits and berries had a similar risk of heart attack as those with a low-risk variant of the same gene.

For the complete article, click here.

Nitric Oxide: The New Hero of Human Biology

Twenty minutes on a treadmill will certainly help you fit into that one-size-too-small dress. But new research suggests that exercise may also help increase the production of nitric oxide, a substance that does a variety of important jobs in the body, perhaps none more valuable than to help prevent heart disease.

“Nitric oxide does a variety of jobs,” explains Dr. Jason Allen of Duke University. “It tends to be antiatherogenic, which means that it helps prevent your arteries from becoming clogged. From start to finish, this is a 40-year process which depends on lifestyle.” That is, it’s a function of what you eat, how you exercise, and the stresses you are under. Continue reading

Breastfed babies develop fewer behavioural problems

Children who are breastfed for four months or more develop fewer behaviour problems, Oxford researchers say.

The study, involving 10,000 mothers and their babies and in journal Archives of Disease in Childhood, says that may be because of the make-up of breast milk.

Or, it says, breastfeeding may lead to better mother-baby interaction.

Breastfeeding is already associated with other health benefits for babies, including lower rates of infection and less obesity in later life.

Researchers looked at the feeding habits of 10,037 mothers and their babies involved in a large study known as theMillennium Cohort Study.

For more of this story, click here.

Prolonged bottle feed increases obesity risk

Babies who are bottle-fed until the age of two are more likely to be obese when they start school, a US study suggests.

Writing in the Journal of Pediatrics, researchers found that children who were still regular bottle users at 24 months were 30% more likely to be obese aged five-and-a-half.

They analysed data from nearly 7,000 children across the United States.

Experts say bottle-feeding can make babies consume too many calories.

The research found 22% of the two-year-olds studied were using a bottle as their main drink container, or were put to bed with a bottle containing a calorie-filled drink.

Nearly a quarter of this group were found to be obese aged five, compared with 16% of children who had not been using a bottle at the age of two.

For more, click here.

 

Priligy (Dapoxetine) can treat Premature Ejaculation (PE)

Priligy® or its generic version Dapoxetine is the first pill-form medication designed specifically to treat premature ejaculation (PE) in men. Premature ejaculation is defined as ejaculating quicker than their partner or themselves would desire.

Technically, Dapoxetine or Priligy® is what is known as a SSRI (selective serotonin reuptake inhibitor). SSRI’s are typically prescribed for patients who experience depression and as such are used as antidepressants. However, some SSRI’s have shown the ability to reduce ejaculation time in some men but no other SSRI in studies has worked as well as Dapoxetine for this issue. Apparently it is also safer and eliminated from the body quicker than typical SSRI’s as its terminal half life is approximately 20 hours with its initial half life around 1.4 hours. This is partially why it was rejected as a depression treatment. Because of its short duration a patient would need to be taking this medication several times per day for a proper effect, which is fairly unrealistic and as such Dapoxetine has not been actually approved as an antidepressant. Continue reading

Drug prevents Type 2 Diabetes in Majority of High-Risk Individuals

A pill taken once a day in the morning prevented type 2 diabetes in more than 70 percent of individuals whose obesity, ethnicity and other markers put them at highest risk for the disease, U.S. scientists report.

The team also noted a 31 percent decrease in the rate of thickening of the carotid artery, the major vessel that supplies blood to the brain. The study, which enrolled 602 participants through The University of Texas Health Science Center San Antonio and seven collaborating centers, is described in the New England Journal of Medicine and has direct implications for the care of 40 million Americans who are pre-diabetic.

“It’s a blockbuster study,” said senior author Ralph DeFronzo, M.D., professor in the School of Medicine and chief of the diabetes division at the UT Health Science Center San Antonio. “The 72 percent reduction is the largest decrease in the conversion rate of pre-diabetes to diabetes that has ever been demonstrated by any intervention, be it diet, exercise or medication.” Continue reading

Eating Apples Extends Lifespan of Test Animals by 10 Percent

Scientists are reporting the first evidence that consumption of a healthful antioxidant substance in apples extends the average lifespan of test animals, and does so by 10 percent. The new results, obtained with fruit flies — stand-ins for humans in hundreds of research projects each year — bolster similar findings on apple antioxidants in other animal tests.

The study appears in ACS’s Journal of Agricultural and Food Chemistry.

Zhen-Yu Chen and colleagues note that damaging substances generated in the body, termed free radicals, cause undesirable changes believed to be involved in the aging process and some diseases. Substances known as antioxidants can combat this damage. Fruits and vegetables in the diet, especially brightly colored foods like tomatoes, broccoli, blueberries, and apples are excellent sources of antioxidants. A previous study with other test animals hinted that an apple antioxidant could extend average lifespan. In the current report, the researchers studied whether different apple antioxidants, known as polyphenols, could do the same thing in fruit flies. Continue reading

Placebo Effect Works Both Ways

Poor expectations of treatment can override all the effect of a potent pain-relieving drug, a brain imaging study at Oxford University has shown.

In contrast, positive expectations of treatment doubled the natural physiological or biochemical effect of the opioid drug among the healthy volunteers in the study.

The study of the placebo effect — and its opposite the nocebo effect — is published in Science Translational Medicine. The findings suggest that doctors may need to consider dealing with patients’ beliefs about the effectiveness of any treatment, as well as determining which drug might be the best for that patient.

‘Doctors shouldn’t underestimate the significant influence that patients’ negative expectations can have on outcome,’ says Professor Irene Tracey of the Centre for Functional Magnetic Resonance Imaging of the Brain at Oxford University, who led the research.

For example, people with chronic pain will often have seen many doctors and tried many drugs that haven’t worked for them. They come to see the clinician with all this negative experience, not expecting to receive anything that will work for them. Doctors have almost got to work on that first before any drug will have an effect on their pain.’

The placebo effect describes the improvements seen when patients — unknowingly — are given dummy pills or sham treatments but believe it will do them good. This is a very real physiological effect; it is not just about patients ‘feeling’ better. The nocebo effect is the opposite: patients see poorer outcomes as the result of doubts about a medical treatment.

Previous studies have investigated the basis of the placebo effect, when using sugar pills or saline injections for example, and confirmed it can elicit a real response.

For the full story, click here.

 

 

Genetically Modified Mosquito released in Malaysia

Some 6000 transgenic mosquitoes developed to help fight dengue were released in Malaysia on 21 December, according to a statement issued by the country’s Institute for Medical Research (IMR) in Kuala Lumpur yesterday. Just like the first releases ever of the mosquitoes, on the Caribbean island of Grand Cayman in 2009 and 2010, the news came as a surprise both to opponents of the insects and to scientists who support them.

The mosquitoes were developed by Oxitec, a U.K. biotech firm that aims to fight dengue by releasing massive numbers of “genetically sterile” male Aedes aegypti mosquitoes. When wild females mate with these transgenic males, there are no viable offspring; the hope is that, as a result, the mosquito populations will collapse.

The news appears to have caught the Malaysian media and public by surprise; many recent news stories reported that the study had been postponed after intense protests.

For the full story, go to http://news.sciencemag.org/scienceinsider/2011/01/gm-mosquito-release-in-malaysia.html?ref=ra